Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Perioperative patient care issues in female pelvic reconstructive surgery

Quinn Lippmann, MD, MPH
Emily S Lukacz, MD, MAS
Section Editor
Linda Brubaker, MD, FACOG
Deputy Editor
Kristen Eckler, MD, FACOG


Urogynecologic surgery is frequently performed to treat symptoms of incontinence and pelvic organ prolapse in women. As an example, in the United States, 20 percent of women are estimated to undergo some type of urogynecologic procedure in their lifetime [1]. While certain elements of urogynecologic surgery are common to all operations, these procedures have unique components that must be addressed by the surgical team.

This topic will review pre-, intra-, and postoperative care issues specific to women undergoing urogynecologic procedures. Information on general planning for benign gynecologic surgery is reviewed separately. (See "Overview of preoperative evaluation and preparation for gynecologic surgery".)


Preparation for urogynecologic surgery includes counseling regarding the unique procedure-related risks, evaluation and testing as directed by the patient's history and symptoms, understanding patient preferences, and recognition of clinical scenarios that require additional action.

Counseling — Preoperatively, the surgeon has a detailed discussion of the risks, benefits, and alternatives to surgery with the patient and her support team, and clearly documents the conversation in the medical record. This conversation addresses potential complications common to all pelvic surgeries and identifies issues unique to each patient's surgical plan.

Universal issues in female reconstructive pelvic surgery — Common potential complications related to female reconstructive pelvic surgery that are discussed and written in the surgical consent include:

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 01, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Wu JM, Matthews CA, Conover MM, et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014; 123:1201.
  2. FDA Safety Communication: Serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm (Accessed on June 16, 2015).
  3. Committee on Gynecologic Practice. Committee Opinion no. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol 2011; 118:1459.
  4. Nager C, Tulikangas P, Miller D, et al. Position statement on mesh midurethral slings for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2014; 20:123.
  5. Tan-Kim J, Menefee SA, Luber KM, et al. Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J 2011; 22:205.
  6. FDA Safety Communication: Laparoscopic uterine power morcellation in hysterectomy and myomectomy http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm424443.htm (Accessed on June 16, 2015).
  7. American Urogynecologic Society’s Guidelines Development Committee. Guidelines for providing privileges and credentials to physicians for transvaginal placement of surgical mesh for pelvic organ prolapse. Female Pelvic Med Reconstr Surg 2012; 18:194.
  8. Brown J. AAGL advancing minimally invasive gynecology worldwide: statement to the FDA on power morcellation. J Minim Invasive Gynecol 2014; 21:970.
  9. Harris JA, Swenson CW, Uppal S, et al. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. Am J Obstet Gynecol 2016; 214:98.e1.
  10. Kwon JS, McAlpine JN, Hanley GE, et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol 2015; 125:338.
  11. Walker JL, Powell CB, Chen LM, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer 2015; 121:2108.
  12. Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005; 106:219.
  13. Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Clin Obstet Gynecol 2007; 50:354.
  14. Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol 2013; 121:709.
  15. Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and Complications of Salpingectomy at the Time of Vaginal Hysterectomy. J Minim Invasive Gynecol 2015; 22:864.
  16. Adams-Piper E, Buono K, Whitcomb E, et al. A Large Retrospective Series of Pregnancy and Delivery After Midurethral Sling for Stress Urinary Incontinence. Female Pelvic Med Reconstr Surg 2016; 22:307.
  17. Siedhoff MT, Clark LH, Hobbs KA, et al. Mechanical bowel preparation before laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol 2014; 123:562.
  18. Ballard AC, Parker-Autry CY, Markland AD, et al. Bowel preparation before vaginal prolapse surgery: a randomized controlled trial. Obstet Gynecol 2014; 123:232.
  19. Arnold A, Aitchison LP, Abbott J. Preoperative Mechanical Bowel Preparation for Abdominal, Laparoscopic, and Vaginal Surgery: A Systematic Review. J Minim Invasive Gynecol 2015; 22:737.
  20. ACOG Committee on Practice Bulletins--Gynecology. ACOG practice bulletin No. 104: Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2009; 113:1180. Reaffirmed 2016.
  21. Till SR, Morgan DM, Bazzi AA, et al. Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone. Am J Obstet Gynecol 2017.
  22. Fok CS, McKinley K, Mueller ER, et al. Day of surgery urine cultures identify urogynecologic patients at increased risk for postoperative urinary tract infection. J Urol 2013; 189:1721.
  23. Nager CW, Brubaker L, Litman HJ, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 2012; 366:1987.
  24. AUGS. Urodynamic testing before stress incontinence surgery: An AUGS position statement. 2012. www.augs.org/p/cm/ld/fid=218 (Accessed on May 24, 2015).
  25. Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol 2014; 123:1403.
  26. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 426: The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol 2009; 113:462.
  27. Kandadai P, Flynn M, Zweizig S, Patterson D. Cost-utility of routine endometrial evaluation before le fort colpocleisis. Female Pelvic Med Reconstr Surg 2014; 20:168.
  28. Shayya RF, Weinstein MM, Lukacz ES. Pyometra after Le Fort colpocleisis resolved with interventional radiology drainage. Obstet Gynecol 2009; 113:566.
  29. Practice Bulletin No. 149: Endometrial cancer. Obstet Gynecol 2015; 125:1006. Reaffirmed 2017.
  30. Alnaif B, Drutz HP. Bacterial vaginosis increases in pessary users. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11:219.
  31. Larsson PG, Carlsson B. Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis? Infect Dis Obstet Gynecol 2002; 10:133.
  32. Yılmaz VT, Avcı AB, Şahin AF, et al. Acute renal failure due to uterine prolapse: a case report. Ren Fail 2013; 35:879.
  33. Moslemi MK, Abedinzadeh M, Nazari A. Obstructive uropathy due to prolapsed lower ureters and bladder in patients with severe procidentia: A report of two cases. Int J Surg Case Rep 2013; 4:348.
  34. Dancz CE, Walker D, Thomas D, Özel B. Prevalence of Hydronephrosis in Women With Advanced Pelvic Organ Prolapse. Urology 2015; 86:250.
  35. Rahn DD, Good MM, Roshanravan SM, et al. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. J Clin Endocrinol Metab 2014; 99:3728.
  36. The universal protocol for preventing wrong site, wrong procedure, and wrong person surgery. http://www.jointcommission.org/assets/1/18/UP_Poster1.PDF (Accessed on May 24, 2015).
  37. Al-Niaimi A, Rice LW, Shitanshu U, et al. Safety and tolerability of chlorhexidine gluconate (2%) as a vaginal operative preparation in patients undergoing gynecologic surgery. Am J Infect Control 2016; 44:996.
  38. Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg 2010; 97:1614.
  39. Thiagamoorthy G, Khalil A, Cardozo L, et al. The value of vaginal packing in pelvic floor surgery: a randomised double-blind study. Int Urogynecol J 2014; 25:585.
  40. Westermann LB, Crisp CC, Oakley SH, et al. To Pack or Not to Pack? A Randomized Trial of Vaginal Packing After Vaginal Reconstructive Surgery. Female Pelvic Med Reconstr Surg 2016; 22:111.
  41. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152:784.
  42. American College of Obstetricians and Gynecologists Women's Health Care Physicians, Committee on Gynecologic Practice. Committee Opinion No. 571: Solutions for surgical preparation of the vagina. Obstet Gynecol 2013; 122:718.
  43. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Number 372. July 2007. The Role of cystourethroscopy in the generalist obstetrician-gynecologist practice. Obstet Gynecol 2007; 110:221.
  44. Jeppson PC, Balgobin S, Rahn DD, et al. Comparison of Vaginal Hysterectomy Techniques and Interventions for Benign Indications: A Systematic Review. Obstet Gynecol 2017.
  45. Westermann L. To pack or not to pack? A randomized trial of vaginal packing after vaginal reconstructive surgery. Female Pelvic Med Reconstr Surg 2016; 11:111.
  46. Khalil KG, Boutrous ML, Irani AD, et al. Operative Intercostal Nerve Blocks With Long-Acting Bupivacaine Liposome for Pain Control After Thoracotomy. Ann Thorac Surg 2015; 100:2013.
  47. Cherian JJ, Barrington J, Elmallah RK, et al. Liposomal Bupivacaine Suspension, Can Reduce Length of Stay and Improve Discharge Status of Patients Undergoing Total Hip Arthroplasty. Surg Technol Int 2015; 27:235.
  48. Yeh CY, Jao SW, Chen JS, et al. Sebacoyl Dinalbuphine Ester Extended-release Injection for Long-acting Analgesia: A Multicenter, Randomized, Double-Blind, And Placebo-controlled Study in Hemorrhoidectomy Patients. Clin J Pain 2017; 33:429.
  49. Mazloomdoost D, Pauls RN, Hennen EN, et al. Liposomal bupivacaine decreases pain following retropubic sling placement: a randomized placebo-controlled trial. Am J Obstet Gynecol 2017; 217:598.e1.
  50. Murphy AM, Tunitsky-Bitton E, Krlin RM, et al. Utility of postoperative laboratory studies after female pelvic reconstructive surgery. Am J Obstet Gynecol 2013; 209:363.e1.
  51. Reagan KML, O'Sullivan DM, Gannon R, Steinberg AC. Decreasing postoperative narcotics in reconstructive pelvic surgery: a randomized controlled trial. Am J Obstet Gynecol 2017; 217:325.e1.
  52. Kalogera E, Dowdy SC. Enhanced Recovery Pathway in Gynecologic Surgery: Improving Outcomes Through Evidence-Based Medicine. Obstet Gynecol Clin North Am 2016; 43:551.
  53. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296:87.
  54. US Department of Health and Human Services. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule. Fed Regist 2009; 74:19385.
  55. American Urological Association white paper on catheter associated urinary tract infections: Definitions and significance in the urologic patient. https://www.auanet.org/common/pdf/education/clinical-guidance/Catheter-Associated-Urinary-Tract-Infections-WhitePaper.pdf (Accessed on June 17, 2015).
  56. Jackson D, Higgins E, Bracken J, et al. Antibiotic prophylaxis for urinary tract infection after midurethral sling: a randomized controlled trial. Female Pelvic Med Reconstr Surg 2013; 19:137.
  57. Shepherd JP, Jones KA, Harmanli O. Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis. Int Urogynecol J 2014; 25:227.
  58. Marschall J, Carpenter CR, Fowler S, et al. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ 2013; 346:f3147.
  59. Juthani-Mehta M. Should antibiotic prophylaxis after urinary catheter removal be standard practice? BMJ 2013; 346:f3938.
  60. Lusardi G, Lipp A, Shaw C. Antibiotic prophylaxis for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev 2013; :CD005428.
  61. Edenfield AL, Siddiqui NY, Wu JM, et al. Polyethylene Glycol 3350 and Docusate Sodium Compared With Docusate Sodium Alone After Urogynecologic Surgery: A Randomized Controlled Trial. Obstet Gynecol 2016; 128:543.
  62. Caruso S, Cianci S, Vitale SG, et al. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse. Menopause 2017; 24:900.
  63. Mueller MG, Lewicky-Gaupp C, Collins SA, et al. Activity Restriction Recommendations and Outcomes After Reconstructive Pelvic Surgery: A Randomized Controlled Trial. Obstet Gynecol 2017; 129:608.
  64. Nygaard IE, Hamad NM, Shaw JM. Activity restrictions after gynecologic surgery: is there evidence? Int Urogynecol J 2013; 24:719.
  65. Yamasato KS, Oyama IA, Kaneshiro B. Intraabdominal pressure with pelvic floor dysfunction: do postoperative restrictions make sense? J Reprod Med 2014; 59:409.
  66. Gerten KA, Richter HE, Wheeler TL 2nd, et al. Intraabdominal pressure changes associated with lifting: Implications for postoperative activity restrictions. Am J Obstet Gynecol 2008; 198:306.e1.
  67. Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA 2014; 311:1023.